72 patient multi-indication trial approved to fast track TRP-8803 commercialisation
Human Research Ethics Committee (HREC) approval secured for world-first phase 1b/2a 8-indication basket study across in 72-patients of TRP-8803 Study will evaluate TRP-8803 (IV-infused psilocin) across eight major disorders with high unmet treatment...